The North America diverticular treatment market was valued at US$ 986.6 million in 2022 and is projected to exceed US$ 1.9 billion by 2031, expanding at a CAGR of 7.6% from 2023 to 2031. Growth is driven by the rising prevalence of diverticular diseases, increasing aging population, and advancements in treatment options, along with improved healthcare infrastructure and awareness across the...